The National Biotechnology Development Agency (NABDA) says its researchers have identified three candidate drugs to be repurposed for the treatment of Lassa fever. Abdullahi Mustapha, director-general of NABDA, disclosed this
Tag "NABDA"
The federal government has launched RNASwift, a diagnostic kit, for the identification of the causal agent of COVID-19. At a press conference on Tuesday, Alex Akpa, director-general of National Biotechnology
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement